Clinical Outcomes in Cyclin-dependent Kinase 12 Mutant Advanced Prostate Cancer.
BRCAness and prostate cancer: diagnostic and therapeutic considerations.
Prostate cancer and prostatic diseases
Heterogeneous drug penetrance of veliparib and carboplatin measured in triple negative breast tumors.
Breast cancer research : BCR
Efficacy and Safety of Olaparib (MK-7339) in Participants With Previously Treated, Homologous R...
ORR is defined as the percentage of participants who achieve a confirmed complete response ([CR]; disappearance of all target lesions) or partial response ([PR]: ≥30% decrease in the sum of diameters of target lesions) as assessed...